Solubilization of Fluasterone in cosolvent/cyclodextrin combinations

International Journal of Pharmaceutics

Volumn 264, Issue 1-2, 2003, Pages 25-34

  He, Yan ^a   Li, Ping ^b   Yalkowsky, Samuel H ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Complexation; Cosolvent; Cyclodextrin; Fluasterone; Mixed solvent; Solubilization

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; ALCOHOL; ANTINEOPLASTIC AGENT; FLUASTERONE; LIGAND; METHANOL; PROPANOL; TRAPPSOL; UNCLASSIFIED DRUG;

ARTICLE; CALCULATION; CONCENTRATION (PARAMETERS); DRUG SOLUBILITY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SOLVENT EFFECT;

EID: 0142028207     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(03)00389-2     Document Type: Article

References (16)

1. Connors K.A. The stability of cyclodextrin complex in solution. Chem. Rev. 97:1997;1325-1357.
2. Evans C.H., Partyka M. Naphthalene complexation by β-cyclodextrin: influence of added short chain branched and linear alcohols. J. Incl. Phenom. Macro. Chem. 38:2000;381-396.
3. Faucci M.T., Mura P. Effect of water-soluble polymers on naproxen complexation with natural and chemically modified β-cyclodextrins. Drug Dev. Ind. Pharm. 27:2001;909-917.
4. Li P., Zhao L., Yalkowsky S.H. Combined effect of cosolvent and cyclodextrin on solubilization of nonpolar drugs. J. Pharm. Sci. 88:1999;1107-1111.
5. Loftsson T., Gudmundsdottir H., Sigurjonsdottir J.F., Sigurdsson H.H., Sigfusson S.D., Masson M., Stefansson E. Cyclodextrin solubilization of benzodiazepines: Formulation of midazolam nasal spray. Int. J. Pharm. 212:2001;29-40.
6. Loftsson T., Olafsdottir B.J., Fridriksdottir H., Jonsdottir S. Cyclodextrin complexations of NSAIDs: physicochemical characteristics. Eur. J. Pharm. Sci. 1:1993;95-101.
7. Loftsson T., Petersen D.S. Cyclodextrin solubilization of ETH-615, a zwitterionic drug. Drug Dev. Ind. Pharm. 24:1998;365-370.
8. Milewski M., Augustyniak W., Maciejewski A. Ternary complexes of 4H-1-benzopyran-4-thione with β-cyclodextrin and alcohols. Dramatic effect of complex formation on fluorescence and phosphorescence intensity. J. Phys. Chem. A. 102:1998;7427-7434.
9. Ono N., Hirayama F., Arima H., Uekama K. Analysis of the phase solubility diagram of a phenacetin/competitor/β-cyclodextrin ternary system, involving competitive inclusion complexation. Chem. Pharm. Bull. 49:2001;78-81.
10. Savolainen J., Jarvinen K., Taipale H., Jarho P., Loftsson T., Jarvinen T. Co-administration of a water-soluble polymer increases the usefulness of cyclodextrins in solid dosage forms. Pharm. Res. 15:1998;1696-1701.
11. Schuette J.M., Ndou T.T., Munoz de la Pena A., Mukundan S., Warner I.M. Influence of alcohols on the β-cyclodextrin/acridine complex. J. Am. Chem. Soc. 115:1993;292-298.
12. Yalkowsky S.H., Flynn G.L., Amidon G.L. Solubilization of nonelectrolytes in polar solvents. J. Pharm. Sci. 61:1972;983-984.
13. Yang, G., Jain, N., Yalkowsky, S.H., 2003. Combined effect of surfactant and complexant on the solubillization of NSC-639829. Int. J. Pharm., KU-2010.
14. Yalkowsky S.H., Rubino J.T. Solubilization by cosolvents: I. Organic solutes in propylene glycol-water mixture. J. Pharm. Sci. 74:1985;416-421.
15. Zhao L., Orton E., Vemuri M. Prediction solubility in multiple nonpolar drugs-cyclodextrin system. J. Pharm. Sci. 91:2002;2301-2306.
16. Zung J.B. Influence of alcohol addition on the γ-CD:pyrene complex. J. Phys. Chem. 95:1991;6701-6709.